Innate Pharma SA Depreciation Property Plant And Equipment Including Rightofuse Assets
Innate Pharma SA (IPHA) reported Depreciation Property Plant And Equipment Including Rightofuse Assets of EUR 1.38 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets · last filed 2026-04-01
| Period end | Depreciation Property Plant And Equipment Including Rightofuse Assets 6 month | Depreciation Property Plant And Equipment Including Rightofuse Assets 12 month |
|---|---|---|
| 2025-12-31 | 1.38M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 707.00K EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 1.58M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 845.00K EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 1.95M EUR 20-F · filed 2026-04-01 | |
| 2022-12-31 | 2.17M EUR 20-F · filed 2025-04-30 |